Navigation Links
Mission Pharmacal Is Proud to Sponsor March for Babies®
Date:4/3/2012

SAN ANTONIO, April 3, 2012 /PRNewswire/ -- Every newborn baby should enter this world healthy.  The people at Mission Pharmacal Company and March of Dimes are dedicated to doing their best to make sure this happens.  That's why Mission Pharmacal is proud to serve as a national corporate sponsor of March of Dimes March for Babies, for the third consecutive year. 

Mission employees raise awareness of infant health issues and educate doctors and mothers-to-be while raising money to support the March of Dimes life-enhancing work and its premier fundraising event, March for Babies.  

"March of Dimes is pleased and proud to have Mission Pharmacal renew and expand its commitment to help give all babies a healthy start in life," says Dr. Jennifer L. Howse, president of the March of Dimes.  "Mission Pharmacal recognizes the need to support community-based programs and research to fight premature birth, infant mortality, and birth defects.  With Mission Pharmacal's assistance, we can also provide comfort and support to the families of babies in newborn intensive care."

"As a national sponsor of March for Babies, our company has helped raise awareness of March of Dimes' important mission," says Natalie Sirjuesingh, vice president of Marketing at Mission Pharmacal.  "In addition, our sales force is helping spread the word about this vitally important challenge and work to physicians and patients.  This is an important partnership for both organizations as we share a commitment to maternal and infant health, and our products can help women have strong, healthy babies.  Together we strive to provide families with a better quality of life.  Please join us by making a donation today." 

March for Babies participants walk together for stronger, healthier babies in nearly 900 communities nationwide, with most walks occurring during the weekend of April 28-29.  Mission Pharmacal corporate based employees and sales representatives across the country will participate in March for Babies.  The Mission team will staff information booths at eight walks including:  San Antonio, Dallas and Houston, TX; Atlanta, GA; Davie, FL; Durham, NC; Newtown, PA; and New York, NY.  At these sites, Mission will provide information about their products that promote infant health, including their CitraNatal® line of prenatal vitamins and Dr. Smith's® Diaper Rash Ointment.

March for Babies is the nation's oldest and largest charitable walking event.  Over the past two years, Mission Pharmacal has raised more than a half million dollars towards the March of Dimes mission.  Since 1970, March for Babies has raised $2 billion for life-saving research to improve the health of babies by preventing birth defects, infant mortality, and premature birth.  To join a team, make a donation or learn more about March for Babies, please visit www.marchforbabies.org.

About Mission Pharmacal
Mission Pharmacal is a privately held pharmaceutical company based in San Antonio, Texas.  For more than 65 years, the company has been committed to meeting the unique healthcare needs of women throughout all stages of life, pediatric patients, and those persons dealing with urologic and dermatologic conditions.  The company has a proven track record of identifying unmet healthcare needs and developing both innovative prescription and over-the-counter products to meet these needs.  Using only the purest ingredients, Mission Pharmacal provides physicians and consumers with the highest quality pharmaceutical and dietary supplement products on the market today.  Mission Pharmacal is a proud national supporter of the March of Dimes Foundation, whose mission is to improve the health of babies by preventing birth defects, premature birth, and infant mortality.  For more information about the company, visit www.missionpharmacal.com.

About the March of Dimes
The March of Dimes is the leading nonprofit organization for pregnancy and baby health. With chapters nationwide and its premier event, March for Babies®, the March of Dimes works to improve the health of babies by preventing birth defects, premature birth and infant mortality. For the latest resources and information, visit marchofdimes.com or nacersano.org.  Find us on Facebook and follow us on Twitter.


'/>"/>
SOURCE Mission Pharmacal
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nektar Consolidates Research at Its State-of-the-Art R&D Center Located in San Francisco at Mission Bay
2. CVS Caremarks Chief Medical Officer Troyen Brennan is Named to the National Commission on Physician Payment Reform
3. Mission Pharmacal Acquires Eletone Cream from Ferndale Healthcare, Inc.
4. Amsterdam Molecular Therapeutics Announces European Commission Delays Decision on Glybera® Marketing Authorisation and Requests Further Information From the CHMP
5. Mission Pharmacal Launches Alamo Pharma Services
6. Call for Submissions: 2012 TripleTree iAwards for Wireless Health
7. The European Commission Grants Marketing Authorization for DIFICLIR™ (fidaxomicin) Tablets for Treatment of Clostridium difficile Infections
8. Former Deputy Commissioner of FDA Highlights Value of Small Distributors
9. Statement from FDA Commissioner Margaret Hamburg, M.D. on Plan B One-Step
10. Omeros Announces Submission to European Medicines Agency of Paediatric Investigation Plan Letter of Intent for OMS302
11. Elsevier and the Fulbright Commission Honor UK Research Talent With the UK Scopus Young Researcher Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading provider of ... that Kyle Allain has joined the company as Vice President and General Manager ... provider, payor and managed care solutions. , A seasoned executive with more ...
(Date:4/24/2017)... ... April 24, 2017 , ... In ... be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research into ... this type of healthcare model in the diagnosis and treatment of brain tumors. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of Gardant ... website. , Rod has been at the forefront of Gardant since it was founded ... Rod has overseen the opening of more than 40 new senior living communities. With ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for her ... good news for single women is that she put all the words in her ... 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her to ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... familiar. This makes it difficult for lab operators and management to assess these ... help them identify wasteful or unnecessary actions. , Created with the help ...
Breaking Medicine News(10 mins):